A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

PHASE2CompletedINTERVENTIONAL
Enrollment

648

Participants

Timeline

Start Date

November 15, 2006

Primary Completion Date

August 1, 2007

Study Completion Date

August 30, 2007

Conditions
Asthma
Interventions
DRUG

GW685698X 200mcg,GW685698X 200mcg and 400mcg

Trial Locations (82)

1000

GSK Investigational Site, Manila

1101

GSK Investigational Site, Quezon City

1431

GSK Investigational Site, Sofia

1606

GSK Investigational Site, Sofia

2050

GSK Investigational Site, Camperdown

2113

GSK Investigational Site, Newtown

2139

GSK Investigational Site, Concord

3001

GSK Investigational Site, Tauranga

3168

GSK Investigational Site, Clayton

3220

GSK Investigational Site, Geelong

4126

GSK Investigational Site, eManzimtoti

5000

GSK Investigational Site, Adelaide

GSK Investigational Site, Veliko Tarnovo

5065

GSK Investigational Site, Toorak Gardens

6000

GSK Investigational Site, Cebu

6009

GSK Investigational Site, Nedlands

6035

GSK Investigational Site, Wellington

6720

GSK Investigational Site, México

7000

GSK Investigational Site, Rousse

7530

GSK Investigational Site, Bellville

7925

GSK Investigational Site, Cape Town

9010

GSK Investigational Site, Varna

9300

GSK Investigational Site, Bloemfontein

10000

GSK Investigational Site, Zagreb

10330

GSK Investigational Site, Bangkok

10367

GSK Investigational Site, Berlin

10400

GSK Investigational Site, Bangkok

10717

GSK Investigational Site, Berlin

13597

GSK Investigational Site, Berlin

21000

GSK Investigational Site, Split

21021

GSK Investigational Site, Vinnitsa

33143

GSK Investigational Site, Miami

34117

GSK Investigational Site, Kassel

35037

GSK Investigational Site, Marburg

40002

GSK Investigational Site, Khon Kaen

43560

GSK Investigational Site, Sylvania

44340

GSK Investigational Site, Guadalajara

45406

GSK Investigational Site, Dayton

49100

GSK Investigational Site, Petah Tikva

53228

GSK Investigational Site, Greenfield

63141

GSK Investigational Site, St Louis

64020

GSK Investigational Site, Monterrey

64460

GSK Investigational Site, Monterrey

76100

GSK Investigational Site, Rehovot

78229

GSK Investigational Site, San Antonio

78360

GSK Investigational Site, Ashkelon

79925

GSK Investigational Site, El Paso

83099

GSK Investigational Site, Donetsk

91120

GSK Investigational Site, Jerusalem

92123

GSK Investigational Site, San Diego

92647

GSK Investigational Site, Huntington Beach

92835

GSK Investigational Site, Fullerton

92868

GSK Investigational Site, Orange

97035

GSK Investigational Site, Lake Oswego

97213

GSK Investigational Site, Portland

97504

GSK Investigational Site, Medford

115478

GSK Investigational Site, Moscow

197022

GSK Investigational Site, Saint Petersburg

420015

GSK Investigational Site, Kazan'

620109

GSK Investigational Site, Yekaterinburg

664005

GSK Investigational Site, Irkutsk

2341131

GSK Investigational Site, Valparaíso

7500551

GSK Investigational Site, Santiago

7500691

GSK Investigational Site, Santiago

8207257

GSK Investigational Site, Puente Alto - Santiago

02747

GSK Investigational Site, North Dartmouth

05403

GSK Investigational Site, South Burlington

A0A 1G0

GSK Investigational Site, Bay Roberts

L6T 3T1

GSK Investigational Site, Brampton

N4S 4G3

GSK Investigational Site, Woodstock

04530

GSK Investigational Site, México

Lima 27

GSK Investigational Site, San Isidro

GSK Investigational Site, Lima

Lima 1

GSK Investigational Site, Lima

656 045

GSK Investigational Site, Barnaul

115 280

GSK Investigational Site, Moscow

634 050

GSK Investigational Site, Tomsk

01004

GSK Investigational Site, Kiev

01601

GSK Investigational Site, Kiev

03680

GSK Investigational Site, Kiev

02091

GSK Investigational Site, Kyiv

03038

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY